MedPath

Artificial Intelligence Self Harm Application

Not Applicable
Not yet recruiting
Conditions
Self-harm
Suicide
Interventions
Behavioral: The Artificial Intelligence intervention for Self-Harm prevention Application (AISHA) is a mobile intervention based on Y-CMAP
Registration Number
NCT06019663
Lead Sponsor
Pakistan Institute of Living and Learning
Brief Summary

This is a mixed-methods study. The quantitative component will comprise of a multicentre rater-blind, randomized controlled trial to evaluate the feasibility and acceptability of AISHA in addition to treatment as usual (TAU) compared to TAU alone in Pakistan.

In-depth interviews and focus groups with other stakeholders will take place to consider the wider implementation of AISHA in mental health services in Pakistan.

Detailed Description

Mental health resources in LMICs, including Pakistan, do not match the burden of mental illness, resulting in a massive mental health treatment gap. Interventions delivered on mobile platforms (M-Health) have the potential to overcome these barriers. Evidence supports the acceptability and efficacy of interventions delivered on digital platforms for a variety of mental disorders. Mobile-based interventions have been developed to target self-harm, however, there is paucity of research supporting their efficacy in LMIC.

To our knowledge there are currently no clinical trials examining the feasibility, acceptability and preliminary efficacy of a culturally adapted CBT informed problem solving intervention delivered on a digital platform for self-harm prevention.We have developed an Artificial Intelligence Self-Harm prevention Application (AISHA) to deliver an evidence-based problem solving intervention (CMAP) for people presenting with self-harm.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
312
Inclusion Criteria
  • All patients presented to the participating family physicians, community health centres, emergency departments or admitted to a general hospital after an episode of self-harm at participating sites.
  • Age 16 to 25 years
  • Participants must be familiar with functioning of handheld mobile devices (mobile phones, tablets).
  • Able to read Urdu or English language.
  • Individuals able to provide written informed consent.
  • Have an android mobile phone/device
Exclusion Criteria
  • Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability which prevents participation.
  • Participants needing inpatient psychiatric treatment as determined by their clinical teams

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionThe Artificial Intelligence intervention for Self-Harm prevention Application (AISHA) is a mobile intervention based on Y-CMAP-
Primary Outcome Measures
NameTimeMethod
Beck Scale for Suicide IdeationChange in scores from baseline to 3-month follow up (end of intervention)

This is a self-report measure of current suicidal ideation. Higher scores (≥6) on the scale indicate greater risk. When measured against other instruments of suicidal ideation, the convergent validity of the BSI has been demonstrated, r= 0. We have used the Urdu translated version of this instrument in prior work from Pakistan and found the Cronbach's alpha to be 0.89 (M. O. Husain et al., 2019). Higher scores indicate greater severity of suicidal ideation

Secondary Outcome Measures
NameTimeMethod
Beck Hopelessness ScaleChange in scores from baseline to 3-month follow up (end of intervention)

This is a 20-item self-report instrument designed to measure three aspects of hopelessness, feelings about the future, loss of motivation and expectations. Higher scores indicate increasing severity of hopelessness; normal (0-3), mild hopelessness (4-8), moderate hopelessness (9-14), severe hopelessness (\>14).

The Problem Solving InventoryChange in scores from baseline to 3-month follow up (end of intervention)

The PSI is a 35-item instrument that measures the individual's perceptions regarding one's problem-solving style and problem-solving abilities in the everyday life. It consists of three subscales. Higher scores indicate higher level of problem solving abilities

Coping resource inventoryChange in scores from baseline to 3-month follow up (end of intervention)

The CRI is a structured instrument to assess the coping resources to manage stress available to an individual. Higher scores indicate better coping skills

The Resilience ScaleChange in scores from baseline to 3-month follow up (end of intervention)

The RS is a 25-item self-report scale that aims to assess an individual's level of resilience. This is a 7 point Likert Scale and provides a total score of resilience, ranging from 25 to 175, with higher scores indicative of higher levels of resilience.

Client Satisfaction QuestionnaireLevel of satisfaction with the services received at end of intervention i.e., 3-month post-randomization

This is an eight item self-report questionnaire used to assess participant's satisfaction with the services using a 4-point likert scale. Higher scores indicate greater satisfaction.

Client Service Receipt InventoryChange in scores from baseline to 3-month follow up (end of intervention)

This instrument is used to collect information on the use of health services (both formal and informal sector such as physician, faith healers/Imams)

Beck Depression InventoryChange in scores from baseline to 3-month follow up (end of intervention)

This is a 21-item scale of depressive symptoms. Higher scores on the scale indicate greater severity of depression. Mild depression is indicated by scores of 14 -19; Moderate depression scores of 20 - 28 and Severe depression scores of 29-63.

Euro-Qol Quality of Life ScaleChange in scores from baseline to 3-month follow up (end of intervention)

This is an instrument which is used to measure quality of life or health profiles of participants. Higher scores indicate higher health related quality of life

Trial Locations

Locations (2)

Benazir Bhutto Hospital

🇵🇰

Rawalpindi, Punjab, Pakistan

Civil Hospital

🇵🇰

Karachi, Sindh, Pakistan

© Copyright 2025. All Rights Reserved by MedPath